An open access, peer - reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more
on tumor immunology and cancer immunotherapy.
Several research groups of the Institute focus
on tumor immunology and cancer immunotherapy.
Not exact matches
«What he showed us is turning the immune system
on isn't enough; the crucial step is to make sure it doesn't turn itself off,» says Antoni Ribas, director of the
tumor immunology program at UCLA's Jonsson Comprehensive Cancer Center.
The Clinical Accelerator, building
on 60 + years of CRI's dedication to funding the most innovative basic science in
tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.
The project associates the expertise of IRIBHM in GPCR discovery and validation, the unique technology
on sensory GPCRs developed by ChemCom, the in - depth
tumor immunology expertise of de Duve with the drug discovery capabilities of iTeos and the expertise of ImmunXperts with human primary cells in immuno - oncology.
Gosselies, Belgium — February 10, 2017 — iTeos Therapeutics SA, a Belgian privately - held biotechnology company applying its expertise in translational
tumor immunology to the development of novel cancer immunotherapies, today announced that Michel Detheux, iTeos» Chief Executive Officer, will present at the 2017 BIO CEO & Investor Conference
on Tuesday, February 14 2017 at 10:45 a.m. ET in Park North at The Waldorf Astoria in New York, NY.
For a while, people were not keen
on anyone who wanted to do
tumor immunology.
For instance, «we're seeing relapses despite the fact» that T cells have swarmed a
tumor and taken aim at molecules
on the malignant cells, said Greenberg, who is also the head of
immunology at the Fred Hutchinson Cancer Research Center.
Using expertise in genomics and cell biology, Dr. Pillai is looking forward to expanding his research in the field of
Tumor Immunology, with focus
on Breast Cancer.